XOM vs CVX vs SHEL
161 measures in 16 categories, one definition each, computed from filings and market data.
XOM62.0
Exxonmobil Holdings Corporation
Energy · Oil & Gas Integrated
$178.98 +2.46%$736.0B mkt cap
Score DNA
Price, rebased to 100 three years ago
XOM CVX SHEL · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 9 | 0 |
| Last Congress purchase | — | 2026-09-02 | — |
| 13F net change in holders | +383 | −160 | −62 |
| ETFs adding shares, 30d | 1,494 | 1,453 | 94 |
| ETFs trimming, 30d | 1,369 | 1,096 | 80 |
| Net ETF funds, 30d | +125 | +357 | +14 |
Valuation
16 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| P/E (TTM) | 22.5x
88th
|
21.6x
75th
|
11.7x
50th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | — | 4.12 |
| Price / sales | 2.0x
75th
|
2.1x
88th
|
1.0x
38th
|
| Price / book | 2.8x
100th
|
2.3x
75th
|
1.7x
12th
|
| Price / tangible book | 2.2x
88th
|
1.8x
38th
|
1.4x
25th
|
| Price / free cash flow | 24.1x
88th
|
16.7x
75th
|
10.0x
38th
|
| Price / operating cash flow | 12.3x
100th
|
9.8x
88th
|
6.3x
75th
|
| Enterprise value | $767.7B
100th
|
$473.1B
88th
|
$345.5B
75th
|
| EV / sales | 2.1x
62nd
|
2.3x
88th
|
1.2x
38th
|
| EV / EBITDA | 10.7x
100th
|
8.5x
88th
|
5.1x
62nd
|
| EV / EBIT | 18.2x
100th
|
14.8x
88th
|
7.7x
62nd
|
| EV / free cash flow | 25.1x
88th
|
17.8x
75th
|
11.4x
12th
|
| Earnings yield | 4.5%
12th
|
4.6%
25th
|
8.5%
50th
|
| FCF yield | 4.2%
12th
|
6.0%
25th
|
10.0%
62nd
|
| Operating cash flow yield | 8.1%
0th
|
10.2%
12th
|
15.8%
25th
|
| Graham number (per share) | $104.75
75th
|
$150.17
100th
|
$115.25
88th
|
Profitability (TTM)
12 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Gross margin | 25.1%
25th
|
31.0%
50th
|
17.9%
0th
|
| EBITDA margin | 19.9%
12th
|
26.7%
50th
|
22.9%
25th
|
| Operating margin | 10.7%
0th
|
15.8%
50th
|
12.3%
25th
|
| EBIT margin | 11.7%
12th
|
15.4%
38th
|
15.2%
25th
|
| Net margin | 9.1%
38th
|
9.9%
62nd
|
8.8%
25th
|
| NOPAT margin | 8.0%
25th
|
10.8%
62nd
|
8.1%
38th
|
| FCF margin | 8.5%
38th
|
12.7%
88th
|
10.3%
75th
|
| Operating cash flow margin | 16.5%
25th
|
21.6%
75th
|
16.2%
12th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.4%
75th
|
| SG&A / revenue | 3.0%
38th
|
5.2%
62nd
|
4.2%
50th
|
| Stock comp / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| Effective tax rate | 25.6%
12th
|
31.6%
50th
|
34.4%
62nd
|
Returns on capital
11 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| ROE (on average equity) | 12.6%
25th
|
12.2%
12th
|
14.3%
38th
|
| ROA | 7.2%
75th
|
7.1%
50th
|
6.8%
38th
|
| ROIC | 9.9%
0th
|
10.3%
12th
|
10.8%
50th
|
| ROCE | 11.2%
38th
|
11.0%
25th
|
15.3%
62nd
|
| Return on tangible assets | 9.2%
12th
|
11.0%
50th
|
11.7%
62nd
|
| Cash ROIC (OCF / invested capital) | 20.5%
12th
|
20.7%
25th
|
21.6%
50th
|
| Gross profitability (GP / assets) | 19.5%
62nd
|
16.7%
38th
|
13.3%
12th
|
| ROIC, 3-yr average | 8.6%
62nd
|
7.5%
38th
|
6.5%
12th
|
| ROIC, 5-yr average | 13.8%
62nd
|
11.9%
38th
|
9.8%
12th
|
| ROE, 5-yr average | 17.0%
62nd
|
14.0%
25th
|
13.2%
12th
|
| Incremental ROIC | — | 25.8%
43rd
|
-509.9%
14th
|
Growth
17 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Revenue growth (TTM YoY) | 9.6%
38th
|
10.3%
50th
|
8.9%
25th
|
| Revenue growth (QoQ) | 37.7%
75th
|
41.3%
88th
|
35.8%
62nd
|
| Revenue CAGR, 3 yr | -0.3%
75th
|
-0.8%
62nd
|
-6.2%
12th
|
| Revenue CAGR, 5 yr | 11.0%
62nd
|
12.5%
75th
|
7.7%
12th
|
| Gross profit CAGR, 3 yr | -3.3%
62nd
|
-5.9%
25th
|
-7.9%
12th
|
| Operating income CAGR, 3 yr | -14.2%
12th
|
-1.1%
75th
|
-9.0%
62nd
|
| Net income growth (TTM YoY) | 5.6%
0th
|
50.0%
38th
|
90.7%
62nd
|
| Net income CAGR, 3 yr | -14.1%
25th
|
-12.0%
38th
|
-3.6%
62nd
|
| EPS growth (TTM YoY) | 9.6%
0th
|
32.0%
25th
|
103.2%
75th
|
| EPS CAGR, 3 yr | -14.9%
25th
|
-13.5%
38th
|
2.8%
75th
|
| EPS CAGR, 5 yr | — | 41.1%
83rd
|
45.3%
100th
|
| FCF growth (TTM YoY) | 4.9%
25th
|
65.2%
88th
|
5.9%
38th
|
| FCF CAGR, 3 yr | -13.0%
38th
|
-1.3%
100th
|
-10.1%
75th
|
| Operating cash flow CAGR, 3 yr | -4.1%
75th
|
3.0%
100th
|
-9.3%
0th
|
| Book value CAGR, 3 yr | 8.3%
88th
|
4.4%
25th
|
4.9%
38th
|
| Dividend CAGR, 3 yr | -0.9%
38th
|
3.9%
62nd
|
6.0%
88th
|
| Sustainable growth rate | 5.9%
25th
|
4.0%
12th
|
9.7%
50th
|
Margin history & stability
7 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Gross margin, 3-yr average | 23.6%
25th
|
26.6%
38th
|
16.4%
0th
|
| Operating margin, 3-yr average | 11.4%
38th
|
11.3%
25th
|
11.2%
12th
|
| Net margin, 3-yr average | 9.5%
62nd
|
8.9%
50th
|
6.6%
12th
|
| FCF margin, 3-yr average | 8.9%
50th
|
10.2%
62nd
|
10.4%
75th
|
| Revenue stability (0-1) | 0.59
88th
|
0.56
75th
|
0.17
12th
|
| Earnings stability (0-1) | 0.21
100th
|
0.02
38th
|
0.01
25th
|
| Margin stability (0-1) | 0.67
0th
|
0.89
38th
|
0.91
50th
|
Liquidity (latest quarter)
7 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Cash & short-term investments | $10.6B
50th
|
$8.5B
12th
|
$31.4B
75th
|
| Net cash (− = net debt) | −$31.8B
50th
|
−$28.5B
75th
|
−$41.7B
25th
|
| Working capital | $12.0B
75th
|
$9.9B
62nd
|
$37.2B
100th
|
| Current ratio | 1.13
38th
|
1.25
62nd
|
1.43
88th
|
| Quick ratio | 0.85
38th
|
0.98
62nd
|
1.12
88th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.12
0th
|
0.22
12th
|
0.37
62nd
|
| Defensive interval (days) | 498 days
25th
|
542 days
38th
|
2,198 days
88th
|
Leverage & solvency (latest quarter)
13 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Total debt | $42.4B
38th
|
$37.1B
25th
|
$73.1B
100th
|
| Debt / equity | 0.16
0th
|
0.20
12th
|
0.40
25th
|
| Net debt / equity | 0.12
0th
|
0.15
12th
|
0.23
38th
|
| Debt / assets | 9.1%
0th
|
11.2%
12th
|
19.2%
25th
|
| Debt / capital | 14.0%
0th
|
16.3%
12th
|
28.8%
25th
|
| Debt / EBITDA | 0.59
12th
|
0.67
25th
|
1.08
50th
|
| Net debt / EBITDA | 0.44
12th
|
0.51
38th
|
0.61
50th
|
| Interest coverage (EBIT / interest) | 65.0x
100th
|
22.5x
88th
|
8.8x
25th
|
| Cash interest coverage | 92.0x
100th
|
31.6x
88th
|
9.4x
38th
|
| Debt payback (years of OCF) | 0.7 yrs
0th
|
0.8 yrs
12th
|
1.5 yrs
38th
|
| Liabilities / assets | 42.7%
12th
|
40.8%
0th
|
52.2%
25th
|
| IS credit model rating | AAA | AA | A |
| Implied credit spread (bps) | 50
0th
|
80
12th
|
150
38th
|
Efficiency
11 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Asset turnover | 0.79
75th
|
0.72
38th
|
0.77
62nd
|
| Fixed asset turnover | 1.22
50th
|
0.97
25th
|
1.62
62nd
|
| Inventory turnover | 10.6
50th
|
15.9
75th
|
9.8
38th
|
| Receivables turnover | 7.1
25th
|
9.9
62nd
|
6.0
0th
|
| Days sales outstanding | 52 days
75th
|
37 days
38th
|
61 days
100th
|
| Days inventory outstanding | 34 days
50th
|
23 days
25th
|
37 days
62nd
|
| Days payables outstanding | 91 days
75th
|
51 days
38th
|
88 days
62nd
|
| Cash conversion cycle (days) | −5 days
25th
|
9 days
50th
|
9 days
62nd
|
| Capex / revenue | 8.1%
25th
|
8.9%
50th
|
5.9%
0th
|
| Capex / depreciation | 0.98
50th
|
0.78
38th
|
0.77
25th
|
| Operating expense ratio | 6.5%
25th
|
13.6%
50th
|
3.5%
0th
|
Cash flow & earnings quality
7 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Operating cash flow / net income | 1.82
25th
|
2.19
75th
|
1.85
38th
|
| FCF / net income | 0.93
50th
|
1.29
88th
|
1.17
75th
|
| FCF / operating cash flow | 51.2%
62nd
|
58.9%
88th
|
63.4%
100th
|
| Capex / operating cash flow | 48.8%
38th
|
41.1%
12th
|
36.6%
0th
|
| Accruals ratio | -5.9%
62nd
|
-8.4%
12th
|
-5.7%
75th
|
| Sloan accruals ratio | -7.6%
25th
|
-4.7%
50th
|
-4.0%
62nd
|
| Earnings quality score (0-1) | 0.75
12th
|
0.75
12th
|
0.75
12th
|
Scores & forensic checks
15 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| IS score | 62
25th
|
74
100th
|
65
62nd
|
| IS profitability | 44
38th
|
64
50th
|
43
25th
|
| IS growth | 51
0th
|
65
50th
|
64
38th
|
| IS value | 58
0th
|
60
25th
|
86
75th
|
| IS momentum | 79
0th
|
91
62nd
|
90
50th
|
| IS risk (safety) | 100
100th
|
80
88th
|
65
62nd
|
| IS quality | 75
12th
|
83
88th
|
80
62nd
|
| IS balance sheet | 74
75th
|
74
88th
|
74
62nd
|
| IS earnings quality | 71
62nd
|
71
50th
|
71
25th
|
| IS cash flow | 59
62nd
|
72
100th
|
59
50th
|
| Piotroski F-score (0-9) | 6
0th
|
7
25th
|
9
88th
|
| Altman Z-score | 4.3
100th
|
3.3
88th
|
2.5
62nd
|
| Beneish M-score | −2.30
75th
|
−6.69
0th
|
−2.62
50th
|
| Ohlson O-score | −10.38
12th
|
−10.50
0th
|
−9.88
25th
|
| IS credit score | 97
100th
|
90
88th
|
74
62nd
|
Size (TTM)
8 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| Market cap | $736.0B
100th
|
$444.5B
88th
|
$303.8B
75th
|
| Revenue | $361.1B
100th
|
$208.7B
62nd
|
$296.2B
88th
|
| EBITDA | $71.8B
88th
|
$55.7B
50th
|
$67.8B
75th
|
| Net income | $32.8B
88th
|
$20.6B
50th
|
$25.9B
75th
|
| Free cash flow | $30.6B
100th
|
$26.6B
75th
|
$30.4B
88th
|
| Total assets | $464.5B
100th
|
$330.1B
75th
|
$380.5B
88th
|
| Shareholders' equity | $259.4B
100th
|
$189.9B
88th
|
$180.8B
75th
|
| Employees | 57,900
62nd
|
43,039
25th
|
84,000
75th
|
Price performance
9 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| 1 day | +2.5% | +2.6% | +3.0% |
| 1 week | +5.9% | +6.1% | +6.5% |
| 1 month | +9.6% | +6.3% | +11.3% |
| 3 months | +21.4% | +18.6% | +23.7% |
| 6 months | +23.9% | +22.3% | +21.5% |
| Year to date | +48.9% | +45.7% | +42.7% |
| 1 year | +65.0% | +49.6% | +49.8% |
| 3 years, cumulative | +85.5% | +54.0% | +76.1% |
| 5 years, cumulative | +242.9% | +147.5% | +170.6% |
Technicals
4 measures| Measure | XOM | CVX | SHEL |
|---|---|---|---|
| RSI 14 | 73.0 | 70.8 | 80.7 |
| From 52-week high | −0.1% | −0.1% | −0.0% |
| From 52-week low | +66.8% | +53.6% | +56.9% |
| Beta | 0.17 | 0.52 | -0.22 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17